JP2013530202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013530202A5 JP2013530202A5 JP2013517372A JP2013517372A JP2013530202A5 JP 2013530202 A5 JP2013530202 A5 JP 2013530202A5 JP 2013517372 A JP2013517372 A JP 2013517372A JP 2013517372 A JP2013517372 A JP 2013517372A JP 2013530202 A5 JP2013530202 A5 JP 2013530202A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- hal
- mixtures
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10168833.1 | 2010-07-08 | ||
| EP10168833 | 2010-07-08 | ||
| US36274610P | 2010-07-09 | 2010-07-09 | |
| US61/362,746 | 2010-07-09 | ||
| PCT/EP2011/061372 WO2012004287A1 (en) | 2010-07-08 | 2011-07-06 | 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013530202A JP2013530202A (ja) | 2013-07-25 |
| JP2013530202A5 true JP2013530202A5 (https=) | 2015-11-05 |
| JP6014589B2 JP6014589B2 (ja) | 2016-10-25 |
Family
ID=42341535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013517372A Expired - Fee Related JP6014589B2 (ja) | 2010-07-08 | 2011-07-06 | スフィンゴシン１−リン酸（ｓ１ｐ）受容体上のリガンドとしての５−（ビフェニル−４−イル）−３−フェニル−１，２，４−オキサジアゾリル誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9029405B2 (https=) |
| EP (1) | EP2590956B1 (https=) |
| JP (1) | JP6014589B2 (https=) |
| KR (1) | KR20140003379A (https=) |
| CN (1) | CN103097365B (https=) |
| AR (1) | AR082132A1 (https=) |
| AU (1) | AU2011275854B2 (https=) |
| CA (1) | CA2804473C (https=) |
| EA (1) | EA201300092A1 (https=) |
| ES (1) | ES2586145T3 (https=) |
| IL (1) | IL224071B (https=) |
| MX (1) | MX2012015021A (https=) |
| SG (1) | SG186872A1 (https=) |
| TW (1) | TW201206429A (https=) |
| WO (1) | WO2012004287A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102250035A (zh) * | 2011-06-10 | 2011-11-23 | 北京富卡生物技术有限公司 | 二芳基取代-1，3，4-噁二唑化合物的合成方法和其药物用途 |
| CN107857760A (zh) * | 2017-11-21 | 2018-03-30 | 南京天翔医药科技有限公司 | 鞘氨醇‑1‑磷酸受体调节剂及其应用 |
| JP7679384B2 (ja) * | 2019-12-23 | 2025-05-19 | シトリクス・セラピューティクス・リミテッド | 抗炎症特性を有するカルボン酸誘導体 |
| KR20220158743A (ko) * | 2020-03-27 | 2022-12-01 | 리셉토스 엘엘씨 | 스핑고신 1 포스페이트 수용체 조절제 |
| US20240228448A1 (en) * | 2021-03-31 | 2024-07-11 | Washington University | Compositions for binding sphingosine-1-phosphate receptor 1 (s1p1), imaging of s1p1, and processes for preparation thereof |
| KR102658761B1 (ko) * | 2021-04-14 | 2024-04-19 | 주식회사 엘지화학 | 스핑고신-1-인산 수용체 효능제 합성을 위한 중간체의 제조방법 |
| US12571867B2 (en) | 2022-04-14 | 2026-03-10 | United States Pharmacopeial Convention | Nuclear magnetic resonance analysis systems and methods |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0711792B1 (de) | 1994-11-05 | 1999-03-10 | BASF Aktiengesellschaft | Melaminharze |
| US7605171B2 (en) * | 2003-12-17 | 2009-10-20 | Merck & Co., Inc. | (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists |
| US20060223866A1 (en) * | 2004-08-13 | 2006-10-05 | Praecis Pharmaceuticals, Inc. | Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity |
| BRPI0612028A2 (pt) * | 2005-06-08 | 2010-10-13 | Novartis Ag | oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p |
| GB0511684D0 (en) * | 2005-06-08 | 2005-07-13 | Novartis Ag | Organic compounds |
| TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
| GB0601744D0 (en) * | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
| JP2009269819A (ja) * | 2006-08-25 | 2009-11-19 | Asahi Kasei Pharma Kk | アミン化合物 |
| RU2009115963A (ru) | 2006-09-29 | 2010-11-10 | Новартис АГ (CH) | Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами |
| ES2622423T3 (es) * | 2007-10-04 | 2017-07-06 | Merck Serono S.A. | Derivados de oxadiazol |
| TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
| EP2241558A1 (en) | 2009-04-03 | 2010-10-20 | Merck Serono SA | Oxadiazole derivatives |
-
2011
- 2011-07-01 TW TW100122179A patent/TW201206429A/zh unknown
- 2011-07-06 JP JP2013517372A patent/JP6014589B2/ja not_active Expired - Fee Related
- 2011-07-06 EA EA201300092A patent/EA201300092A1/ru unknown
- 2011-07-06 MX MX2012015021A patent/MX2012015021A/es not_active Application Discontinuation
- 2011-07-06 KR KR20137003335A patent/KR20140003379A/ko not_active Withdrawn
- 2011-07-06 US US13/809,013 patent/US9029405B2/en not_active Expired - Fee Related
- 2011-07-06 ES ES11729318.3T patent/ES2586145T3/es active Active
- 2011-07-06 EP EP11729318.3A patent/EP2590956B1/en not_active Not-in-force
- 2011-07-06 CN CN201180033823.9A patent/CN103097365B/zh not_active Expired - Fee Related
- 2011-07-06 SG SG2012096533A patent/SG186872A1/en unknown
- 2011-07-06 CA CA2804473A patent/CA2804473C/en not_active Expired - Fee Related
- 2011-07-06 WO PCT/EP2011/061372 patent/WO2012004287A1/en not_active Ceased
- 2011-07-06 AU AU2011275854A patent/AU2011275854B2/en not_active Ceased
- 2011-07-08 AR ARP110102449 patent/AR082132A1/es not_active Application Discontinuation
-
2012
- 2012-12-31 IL IL224071A patent/IL224071B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013530202A5 (https=) | ||
| JP2016500661A5 (https=) | ||
| JP2012500260A5 (https=) | ||
| JP2020505376A5 (https=) | ||
| JP2006524660A5 (https=) | ||
| JP2017519754A5 (https=) | ||
| JP2013530238A5 (https=) | ||
| JP2013530236A5 (https=) | ||
| JP2015502387A5 (https=) | ||
| JP2006509719A5 (https=) | ||
| JP2014520898A5 (https=) | ||
| JP2008513498A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2014508811A5 (https=) | ||
| JP2013533883A5 (https=) | ||
| JP2020506951A5 (https=) | ||
| JP2014507455A5 (https=) | ||
| JP2019519587A5 (https=) | ||
| JP2019513745A (ja) | ピロロ［１，２−ａ］ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用 | |
| HRP20100020T1 (hr) | Novi derivati hidantoina za liječenje opstruktivnih bolesti dišnih putova | |
| JP2020500916A5 (https=) | ||
| JP2009538910A5 (https=) | ||
| JP2018529737A5 (https=) | ||
| JP2015502371A5 (https=) | ||
| SG178902A1 (en) | (thio)morpholine derivatives as s1p modulators |